OptimizeRx Corporation
OPRX
$6.60
$0.172.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.13M | 34.00K | -9.87M | -15.41M | -20.11M |
| Total Depreciation and Amortization | 4.33M | 4.33M | 4.33M | 4.34M | 4.33M |
| Total Amortization of Deferred Charges | 1.11M | 1.08M | 1.10M | 847.00K | 835.00K |
| Total Other Non-Cash Items | 7.33M | 8.02M | 16.15M | 17.57M | 19.16M |
| Change in Net Operating Assets | 816.00K | -1.64M | -1.31M | -704.00K | 671.00K |
| Cash from Operations | 18.72M | 11.83M | 10.41M | 6.64M | 4.89M |
| Capital Expenditure | -58.00K | -64.00K | -72.00K | -107.00K | -112.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 126.00K | -194.00K | -268.00K | -274.00K | -338.00K |
| Cash from Investing | 68.00K | -258.00K | -340.00K | -381.00K | -450.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.00M | -8.00M | -8.00M | -4.00M | -4.00M |
| Issuance of Common Stock | 352.00K | 338.00K | -- | -- | -- |
| Repurchase of Common Stock | -1.15M | -512.00K | -448.00K | -858.00K | -911.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.80M | -8.17M | -8.45M | -4.86M | -4.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.99M | 3.39M | 1.63M | 1.40M | -472.00K |